Search - tctmd.com

Displaying 341 - 350 of 350

Sort: Relevancy | Date

Presentation TCT 2013

Navigating a Rocky Crossing - PCI for Complex Calcific Disease in a High Risk Patient

Presenter: Nigel Jepson

October 30, 2013

Presentation

Routine Early Eptifibatide vs. Delayed Provisional Use at PCI in High-Risk NSTE-ACS Patients

Presenter: A. Bagai

August 06, 2013

Presentation

A Prediction Model to Identify Patients at High Risk for 30-Day Readmission After PCI

Presenter: J.H. Wasfy

July 11, 2013

Presentation Fellows 2013

High-Risk PCI and Cardiogenic Shock: The Role of Hemodynamic Support

Presenter: Issam Moussa

April 16, 2013

Presentation TCT 2012

TCT-68. The Use of Percutaneous Left Ventricular Assist Device vs. Intra-aortic Balloon Pump for Hemodynamic Support During High Risk PCI

Presenter: William O'Neill

October 23, 2012

Presentation TCT 2012

Utility of Scoring Systems in High Risk PCI Stratification

Presenter: Davide Capodanno

October 22, 2012

Presentation

PROTECT II: Prospective Randomized Clinical Trial of Hemodynamic Support with Impella 2.5 vs. Intra-aortic Balloon Pump in High-Risk PCI

Presenter: William W. O?Neill

September 07, 2012

Presentation TCT Mediterranean 2012

Adjunct Pharmacology for High-Risk PCI

Presenter: George D. Dangas

May 04, 2012

Presentation Fellows 2012

High-Risk PCI and Cardiogenic Shock: Prognosis and Percutaneous Hemodynamic Support Devices

Presenter: James Goldstein

April 21, 2012

Presentation TCT 2012

Cost-effectiveness and Clinical Outcomes of Impella Hemodynamic Support Compared with Intra- Aortic Balloon Pump in High Risk Patients Receiving PCI: Results from the PROTECT II Trial

Presenter: Brijeshwar Maini, William O?Neill, Simon Dixon, Igor Palacios, Theodore Schreiber, David A. Gregory, D. J. Scotti

January 03, 2012

Advertisement

Navigating a Rocky Crossing - PCI for Complex Calcific Disease in a High Risk Patient

Routine Early Eptifibatide vs. Delayed Provisional Use at PCI in High-Risk NSTE-ACS Patients

A Prediction Model to Identify Patients at High Risk for 30-Day Readmission After PCI

High-Risk PCI and Cardiogenic Shock: The Role of Hemodynamic Support

TCT-68. The Use of Percutaneous Left Ventricular Assist Device vs. Intra-aortic Balloon Pump for Hemodynamic Support During High Risk PCI

Utility of Scoring Systems in High Risk PCI Stratification

PROTECT II: Prospective Randomized Clinical Trial of Hemodynamic Support with Impella 2.5 vs. Intra-aortic Balloon Pump in High-Risk PCI

Adjunct Pharmacology for High-Risk PCI

High-Risk PCI and Cardiogenic Shock: Prognosis and Percutaneous Hemodynamic Support Devices

Cost-effectiveness and Clinical Outcomes of Impella Hemodynamic Support Compared with Intra- Aortic Balloon Pump in High Risk Patients Receiving PCI: Results from the PROTECT II Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content